Salvianolic Acid B Alleviates Liver Injury by Regulating Lactate-Mediated Histone Lactylation in Macrophages.

Shian Hu, Zehua Yang, Ling Li, Qinwen Yan, Yutong Hu, Feng Zhou, Yang Tan, Gang Pei
Author Information
  1. Shian Hu: College of Pharmacy, Hunan University of Chinese Medicine, Changsha 410000, China.
  2. Zehua Yang: Hunan Drug Inspection Center, Changsha 410000, China.
  3. Ling Li: College of Pharmacy, Hunan University of Chinese Medicine, Changsha 410000, China.
  4. Qinwen Yan: College of Pharmacy, Hunan University of Chinese Medicine, Changsha 410000, China.
  5. Yutong Hu: College of Pharmacy, Hunan University of Chinese Medicine, Changsha 410000, China.
  6. Feng Zhou: College of Pharmacy, Hunan University of Chinese Medicine, Changsha 410000, China.
  7. Yang Tan: College of Pharmacy, Hunan University of Chinese Medicine, Changsha 410000, China. ORCID
  8. Gang Pei: College of Pharmacy, Hunan University of Chinese Medicine, Changsha 410000, China.

Abstract

Salvianolic acid B (Sal B) is the primary water-soluble bioactive constituent derived from the roots of Bunge. This research was designed to reveal the potential mechanism of Sal B anti-liver injury from the perspective of macrophages. In our lipopolysaccharide-induced M1 macrophage model, Sal B showed a clear dose-dependent gradient of inhibition of the macrophage trend of the M1 type. Moreover, Sal B downregulated the expression of lactate dehydrogenase A (LDHA), while the overexpression of LDHA impaired Sal B's effect of inhibiting the trend of macrophage M1 polarization. Additionally, this study revealed that Sal B exhibited inhibitory effects on the lactylation process of histone H3 lysine 18 (H3K18la). In a ChIP-qPCR analysis, Sal B was observed to drive a reduction in H3K18la levels in the promoter region of the LDHA, NLRP3, and IL-1β genes. Furthermore, our in vivo experiments showed that Sal B has a good effect on alleviating CCl-induced liver injury. An examination of liver tissues and the Kupffer cells isolated from those tissues proved that Sal B affects the M1 polarization of macrophages and the level of histone lactylation. Together, our data reveal that Sal B has a potential mechanism of inhibiting the histone lactylation of macrophages by downregulating the level of LDHA in the treatment of liver injury.

Keywords

References

  1. Sci Adv. 2021 Jun 23;7(26): [PMID: 34162546]
  2. Int Immunopharmacol. 2023 Sep;122:110550 [PMID: 37451016]
  3. Sci Rep. 2022 Aug 16;12(1):13857 [PMID: 35974091]
  4. Cell Mol Immunol. 2022 Apr;19(4):504-515 [PMID: 34983946]
  5. Cell Metab. 2023 Aug 8;35(8):1406-1423.e8 [PMID: 37463576]
  6. Curr Opin Biotechnol. 2021 Apr;68:282-291 [PMID: 33770632]
  7. Gut. 2022 Dec;71(12):2539-2550 [PMID: 35140065]
  8. Front Physiol. 2021 Oct 18;12:688485 [PMID: 34733170]
  9. J Gen Physiol. 1927 Mar 7;8(6):519-30 [PMID: 19872213]
  10. FEBS J. 2020 Aug;287(16):3350-3369 [PMID: 32255251]
  11. Cell Rep. 2022 Feb 15;38(7):110391 [PMID: 35172156]
  12. Hepatology. 2023 Dec 1;78(6):1800-1815 [PMID: 36651176]
  13. Nat Commun. 2017 Oct 3;8(1):766 [PMID: 28974683]
  14. Antioxidants (Basel). 2022 Jul 19;11(7): [PMID: 35883885]
  15. Sci Adv. 2023 Feb 3;9(5):eadc9465 [PMID: 36735787]
  16. Eur J Pharmacol. 2020 Mar 15;871:172916 [PMID: 31930970]
  17. J Hazard Mater. 2024 Jan 5;461:132582 [PMID: 37742376]
  18. Mol Cancer. 2023 Sep 8;22(1):151 [PMID: 37684641]
  19. Front Immunol. 2022 Oct 21;13:936167 [PMID: 36341426]
  20. Molecules. 2023 Dec 01;28(23): [PMID: 38067630]
  21. J Hepatol. 2017 May;66(5):1037-1046 [PMID: 28167322]
  22. Phytomedicine. 2022 Dec;107:154435 [PMID: 36155216]
  23. Clin Transl Med. 2022 Mar;12(3):e765 [PMID: 35340126]
  24. Immunity. 2021 Sep 14;54(9):2101-2116.e6 [PMID: 34469775]
  25. Nature. 2019 Oct;574(7779):492-493 [PMID: 31645737]
  26. Exp Ther Med. 2021 Apr;21(4):341 [PMID: 33732314]
  27. Cancer Sci. 2021 Aug;112(8):3050-3063 [PMID: 34110068]
  28. J Hypertens. 2022 Jun 1;40(6):1189-1198 [PMID: 35703881]
  29. Can J Physiol Pharmacol. 2020 Mar;98(3):162-168 [PMID: 31604020]
  30. Cell Rep. 2015 Jul 7;12(1):102-115 [PMID: 26119735]
  31. Cell Mol Immunol. 2021 Sep;18(9):2114-2127 [PMID: 34321623]
  32. Adv Drug Deliv Rev. 2021 Sep;176:113869 [PMID: 34280515]
  33. Theranostics. 2023 Jun 19;13(11):3568-3581 [PMID: 37441601]
  34. Cell Death Discov. 2021 Nov 27;7(1):368 [PMID: 34839365]
  35. Front Immunol. 2021 Mar 29;12:630380 [PMID: 33854503]
  36. Cell Death Dis. 2018 May 22;9(6):599 [PMID: 29789538]
  37. Biomed Pharmacother. 2023 Feb;158:114164 [PMID: 36916398]
  38. J Proteome Res. 2021 Jul 2;20(7):3734-3748 [PMID: 34080425]
  39. Cytokine Growth Factor Rev. 2022 Dec;68:81-92 [PMID: 36376165]
  40. Redox Biol. 2020 Sep;36:101634 [PMID: 32863213]
  41. Int J Biol Sci. 2023 Jan 16;19(3):897-915 [PMID: 36778129]
  42. Semin Cancer Biol. 2022 Nov;86(Pt 2):93-100 [PMID: 36096316]
  43. Am J Respir Cell Mol Biol. 2021 Jan;64(1):115-125 [PMID: 33074715]
  44. Immunity. 2019 Dec 17;51(6):997-1011.e7 [PMID: 31851905]
  45. J Proteome Res. 2023 Dec 1;22(12):3683-3691 [PMID: 37897433]
  46. Nat Protoc. 2018 Oct;13(10):2362-2386 [PMID: 30258175]
  47. Nature. 2019 Oct;574(7779):575-580 [PMID: 31645732]
  48. J Pharmacol Sci. 2020 Jul;143(3):165-175 [PMID: 32387002]
  49. Circ Res. 2022 Nov 11;131(11):893-908 [PMID: 36268709]
  50. Int J Mol Sci. 2019 Dec 29;21(1): [PMID: 31905745]
  51. Animals (Basel). 2023 Jan 18;13(3): [PMID: 36766230]
  52. Front Immunol. 2023 Apr 06;14:1128358 [PMID: 37090724]
  53. Adv Sci (Weinh). 2023 Dec 3;:e2306457 [PMID: 38044275]

Grants

  1. 82174271/National Natural Science Foundation of China
  2. 202302/Key Discipline Project on Chinese Parmacology of Hunan University of Chinese Medicine

MeSH Term

Lactic Acid
Histones
Liver
Macrophages
Lactate Dehydrogenase 5
Benzofurans
Depsides

Chemicals

Lactic Acid
Histones
salvianolic acid B
Lactate Dehydrogenase 5
Benzofurans
Depsides

Word Cloud

Created with Highcharts 10.0.0BSalLDHAinjurymacrophagesM1lactylationhistonelivermacrophageH3K18laSalvianolicacidrevealpotentialmechanismshowedtrendeffectinhibitingpolarizationtissueslevelprimarywater-solublebioactiveconstituentderivedrootsBungeresearchdesignedanti-liverperspectivelipopolysaccharide-inducedmodelcleardose-dependentgradientinhibitiontypeMoreoverdownregulatedexpressionlactatedehydrogenaseoverexpressionimpairedB'sAdditionallystudyrevealedexhibitedinhibitoryeffectsprocessH3lysine18ChIP-qPCRanalysisobserveddrivereductionlevelspromoterregionNLRP3IL-1βgenesFurthermorevivoexperimentsgoodalleviatingCCl-inducedexaminationKupffercellsisolatedprovedaffectsTogetherdatadownregulatingtreatmentAcidAlleviatesLiverInjuryRegulatingLactate-MediatedHistoneLactylationMacrophagessalvianolic

Similar Articles

Cited By